Clinical and immunological characteristics of twenty patients with DiGeorge syndrome;Características clínicas e inmunológicas de veinte pacientes con síndrome de DiGeorge

Revista Espanola de Pediatria

Volumn 61, Issue 3, 2005, Pages 201-206

  Passero, L M ^a   Contreras, P ^a   Gonzalez B ^b   Carrion F ^c   Navarrete, C ^d   Mendez C ^a,e   Quezada, A ^f   King, A ^b   Talesnik, Eduardo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Hospital Dr Luis Calvo Mackenna   (Chile)

^c Universidad De Los Andes Facultad de Medicina   (Venezuela)

^d HOSPITAL ROBERTO DEL RÍO   (Chile)

^e HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^f Hospital Exequiel González Cortez   (United States)

Author keywords

Chomosome abnormalities; Chromosomes; DiGeorge syndrome; Human; Pair 22

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

AORTA ARCH; CHILE; CHROMOSOME 22Q; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; DIGEORGE SYNDROME; FACE DYSMORPHIA; FALLOT TETRALOGY; FEMALE; FOLLOW UP; HOSPITAL CARE; HUMAN; HYPOCALCEMIA; IMMUNOPATHOLOGY; INFANT; MALE; MULTICENTER STUDY; PARATHYROID DISEASE; RECURRENT INFECTION; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; REVIEW;

EID: 21744451155     PISSN: 0034947X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. DiGeorge AM. Congenital absence of the thymus and its immunological consequences: concurrence with congenital hypoparathyroidsm. Birth Defects 1968; 4: 116-21.
2. Greenberg F. What defines DiGeorge anomaly? J Pediatr 1989; 115: 412-3.
3. Conley ME, Beckwith JB, Mancer JFK, Tenckhoff L. The spectrum of the Di George syndrome. J Pediatr 1979; 94: 883-90.
4. Muller W, Peter H, Wilken M, Jüppner H, Kallfelz HC, Krohn H, et al. The DiGeorge Syndrome, Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 1988; 147: 496-502.
5. Muller W, Peter HH, Kalfelz HC, Franz A, Rieger CH. The DiGeorge sequence II. Immunological findings in complete and partial forms of the disorder. Eur J Pediatr 1989; 149: 96-103.
6. Van Mierop LHS, Kutsche LM. Cardiovascular anomalies in DiGeorge Syndrome and importance of neural crest as a possible pathogenetic factor. Am J Cardiol 1986; 58: 133-7.
7. Chinen J, Rosenblatt H, Smith O'Brian E, Shearer W, Noroski L. Long -Term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 2003; 111: 573-9.
8. Jawad A, Mc Donald-Mc Ginn D, Zackai E, Sullivan K. Immunologic features of Chromosome 22q11.2 deletion Syndrome (DiGeorge syndrome / velocardiofacial syndrome). J Pediatrics 2001; 139: 715-23.
9. Aglony M, Lizama M, Méndez C, Navarrete C, Garay F, Repetto G, et al. Manifestaciones clínicas y variabilidad inmunológica en nueve pacientes con síndrome de Di George. Rev Med Chile 2004; 132: 26-32.
10. Deerojanawong J, Chang AB, Eng PA, Robertson CF, Kemp AS. Pulmonary disease in children with Severe Combined Immune Deficiency and DiGeorge Syndrome. Pediatr.Pulmonol. 1997; 24: 324-30.
11. Markert ML, Majure M, Harville TO, Hulka Gregory, Oldham. Severe Laringomalacia and Bronchomalacia in DiGeorge Syndrome and. CHARGE Associacion. Pediatric Pulmonol 1997; 24: 364-9.
12. Muñoz S, Garay F, Flores I, Heusser F, Talesnik E, Aracena M, et al. Heterogeneidad de la presentación clínica del síndrome de microdeleción del cromosoma 22, region q11. Rev Méd Chile 2001; 129: 515-21.
13. Burn J, Wilson Di, Scambler P, Goodsiip JD. DiGeorge Syndrome: Part of CACHT 22. J Med Genet 1993; 30: 852-56.
14. Driscoll DA, Salvin J, Sellinger B. Prevalence of 22q11 microdeletion in DiGeorge syndrome and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 1993; 30: 813-7.
15. Lyall H, Eden O, Dixon R, Sutherland R, Thomson A. Assessment of a clinical scoring system for detection of immunodeficiency in children with recurrent infections. Pediatr Infect Dis J 1991; 10: 673-76.
16. Comans Bitter WM, de Groot R, van der Beernd R, Nejems HJ, Wirn CJ, Hap J et al. Inmunophenotyping of blood lymphocytes in childhood. J Pediatr 1997; 130: 388-93.
17. Pérez E, Sullivan K. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr 2002; 14: 678-83.
18. Oskardóttir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in western Sweden. Arch Dis Child 2004; 89: 148-51.
19. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima I, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003; 362: 1366-73.
20. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, et al. A population-based study of the 22q11.2 deletion:, phenotipe, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112: 101-7.
21. McElhinney DB, Discroll DA, Levin ER, Jawad AF, Emanuel BS, Goldmuntz E. Chromosome 22q11.2 Deletion in patients with ventricular septal defect: frequency and associated cardiovascular anomalies. Pediatrics 2003; 112: 472-6.
22. McDonald-McGinn DM, Discroll DA, Emanuel BS, Goldmuntz E, Clark BIIIJ, Solot C, Cohen M, et al. Detection of a 22q11.2 Deletion in Cardiac Patients Suggests a Risk for Velopharyngeal Incompetence. Pediatrics 1997; 99.
23. Huang RY, Shapiro NL. Structural airway anomalies in patients with DiGeorge Syndrome: A current review. Am J Otolaryngol 2000; 21: 326-30.
24. Junker AK, Driscoll DA. Humoral immunity in DiGeorge Syndrome. J Pediatr 1995; 127: 231-7.
25. Gennery AR, Borge D, O'Sullivan JJ, Flood TJ, Abinum M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 2002; 86: 422-5.
26. Bastian J, Law SH, Vogler L, Lawton H, Herrod H, Anderson S, Horowitz SH, Hong R. Prediction of persistent immunodeficiency DiGeorge anomaly. J Pediatr 1989; 115: 391-6.